About Orthopedic Devices
Orthopedics is a branch of medicine that deals with deformities in bone structure, injuries, and disorders of the skeleton and associated structures such as the ligaments and tendons. Orthopedic devices and implants treat injuries and deformities using spinal surgery, joint replacement or reconstruction, and trauma fixation. Joint replacement surgeries are commonly performed in the hip, elbow, knee, wrist, ankle, shoulder, and fingers. Orthopedic implants are usually made from titanium and stainless steel alloy. They are often coated with plastic due to its properties such as resistance to corrosion, rigidity, fracture toughness, stiffness, long fatigue life, and biocompatibility.
Technavio’s analysts forecast the orthopedic devices market in Japan to grow at a CAGR of 4.12% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the orthopedic devices market in Japan for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
Technavio's report, Orthopedic Devices Market in Japan 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Technavio Announces the Publication of its Research Report – Orthopedic Devices Market in Japan 2017-2021
Technavio recognizes the following companies as the key players in the orthopedic devices market in Japan: DePuy Synthes, Medtronic, Smith & Nephew, Stryker, and Zimmer Biomet.
Other Prominent Vendors in the market are: Acumed, Arthrex, Arthrosurface, B. Braun Melsungen, Berkeley Advanced Biomaterials, Bioplate, Foot and Ankle Fixation, Integra LifeSciences Corporation, Kelyniam Global, MicroPort Scientific Corporation, NuVasive, Orthofix Holdings, OsteoMed, and OsteoSymbionics.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is technological advances. The orthopedics devices market in Japan has witnessed several changes over the past few decades. Advances in materials and the advent of computer-aided manufacturing and robot-assisted surgeries have driven the growth of the market. Technological advances and the availability of low-cost products are likely to drive the growth of the orthopedic devices market in Japan.”
According to the report, one driver in the market is rapidly growing aging population with orthopedic disorders. Japan is witnessing a rapid growth in the aging population, which is a trend that is likely to continue during the forecast period. The aging population is more prone to spinal disorders such as degenerative disc disease, scoliosis, and spondylolisthesis when compared with people from other age groups. In addition, the prevalence of obesity, back pain, diabetes mellitus, hypertension, and osteoarthritis has also increased among the aging population. According to the OECD, the aging population in Japan is expected to increase from 23% in 2010 to 39% in 2050.
Further, the report states that one challenge in the market is risks and complications associated with orthopedic devices. Orthopedic devices, implants, and grafts are made from synthetic or biological implantable materials. They are placed inside the body through surgery to correct different clinical conditions. The increasing volume of surgeries performed every year and advances in technology have dramatically increased the demand for grafts, devices, and implants. However, there are several post-operative complications associated with orthopedic devices. For bone graft, the graft eventually breaks down and is replaced with a new bone. Implants also cause several complications.
DePuy Synthes, Medtronic, Smith & Nephew, Stryker, and Zimmer Biomet, Acumed, Arthrex, Arthrosurface, B. Braun Melsungen, Berkeley Advanced Biomaterials, Bioplate, Foot and Ankle Fixation, Integra LifeSciences Corporation, Kelyniam Global, MicroPort Scientific Corporation, NuVasive, Orthofix Holdings, OsteoMed, and OsteoSymbionics.